A novel neural network-based nearest neighbor approach for drug function prediction from chemical structures

IF 4.7 3区 医学 Q1 PHARMACOLOGY & PHARMACY European journal of pharmacology Pub Date : 2025-04-15 Epub Date: 2025-02-11 DOI:10.1016/j.ejphar.2025.177360
Pranab Das , Dilwar Hussain Mazumder
{"title":"A novel neural network-based nearest neighbor approach for drug function prediction from chemical structures","authors":"Pranab Das ,&nbsp;Dilwar Hussain Mazumder","doi":"10.1016/j.ejphar.2025.177360","DOIUrl":null,"url":null,"abstract":"<div><div>Drug function prediction is a crucial task in drug discovery, design, and development, which involves the prediction of the biological functions of a drug molecule based on its chemical structure. Misleading drug function is a common reason for adverse drug reactions and drug failures. A computational approach can aid in correctly identifying drug functions during clinical testing. Therefore, this study proposes a neural network-based nearest neighbor approach using the Multi-Label Convolutional Neural Network and Nearest Neighbor (MLCNN-NN) method to identify drug functions from chemical 2D structures. This model is built upon the hypothesis that chemical compounds (drugs) with similar molecular structures are likely to exhibit similar drug functions, and the drug functions that occur together are likely to share similar chemical structures. The findings illustrate that the presented models can accurately predict the functions of drugs and outperform the performance of ResNet50, DenseNet201, MobileNetv2, Inceptionv3, VGG19, Graph Convolutional Network (GCN) and Meyer et al. models. The proposed model is evaluated on a benchmark dataset of drug molecules with known functions and achieves the highest accuracy value of 98.10%. Moreover, the identification and visualization of co-occurring drug functions serve as solid indicators of the effectiveness of the proposed model in detecting potential co-occurrence of drug functions, with detection rates of 84.02%. The results demonstrate the effectiveness of the MLCNN-NN model in drug function prediction. They also highlight the potential of a multi-label neural network-based nearest neighbor approach, which utilizes convolutional neural network and nearest-neighbor methods, in drug discovery, design, and development.</div></div>","PeriodicalId":12004,"journal":{"name":"European journal of pharmacology","volume":"993 ","pages":"Article 177360"},"PeriodicalIF":4.7000,"publicationDate":"2025-04-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European journal of pharmacology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S001429992500113X","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/11 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Drug function prediction is a crucial task in drug discovery, design, and development, which involves the prediction of the biological functions of a drug molecule based on its chemical structure. Misleading drug function is a common reason for adverse drug reactions and drug failures. A computational approach can aid in correctly identifying drug functions during clinical testing. Therefore, this study proposes a neural network-based nearest neighbor approach using the Multi-Label Convolutional Neural Network and Nearest Neighbor (MLCNN-NN) method to identify drug functions from chemical 2D structures. This model is built upon the hypothesis that chemical compounds (drugs) with similar molecular structures are likely to exhibit similar drug functions, and the drug functions that occur together are likely to share similar chemical structures. The findings illustrate that the presented models can accurately predict the functions of drugs and outperform the performance of ResNet50, DenseNet201, MobileNetv2, Inceptionv3, VGG19, Graph Convolutional Network (GCN) and Meyer et al. models. The proposed model is evaluated on a benchmark dataset of drug molecules with known functions and achieves the highest accuracy value of 98.10%. Moreover, the identification and visualization of co-occurring drug functions serve as solid indicators of the effectiveness of the proposed model in detecting potential co-occurrence of drug functions, with detection rates of 84.02%. The results demonstrate the effectiveness of the MLCNN-NN model in drug function prediction. They also highlight the potential of a multi-label neural network-based nearest neighbor approach, which utilizes convolutional neural network and nearest-neighbor methods, in drug discovery, design, and development.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于神经网络的化学结构药物功能预测新方法。
药物功能预测是药物发现、设计和开发中的一项重要任务,它涉及到基于药物分子的化学结构对其生物功能的预测。误导药物功能是药物不良反应和药物失败的常见原因。一种计算方法可以帮助在临床试验中正确识别药物功能。因此,本研究提出了一种基于神经网络的最近邻方法,利用多标签卷积神经网络和最近邻(MLCNN-NN)方法从化学二维结构中识别药物功能。该模型建立在具有相似分子结构的化合物(药物)可能表现出相似的药物功能的假设之上,并且一起发生的药物功能可能具有相似的化学结构。研究结果表明,该模型可以准确预测药物的功能,并且优于ResNet50、DenseNet201、MobileNetv2、Inceptionv3、VGG19、Graph Convolutional Network (GCN)和Meyer等模型的性能。该模型在已知功能的药物分子基准数据集上进行了评估,准确率最高达到98.10%。此外,共现药物功能的识别和可视化是该模型检测潜在共现药物功能有效性的坚实指标,检出率为84.02%。结果证明了MLCNN-NN模型在药物功能预测中的有效性。他们还强调了基于多标签神经网络的最近邻方法在药物发现、设计和开发中的潜力,该方法利用卷积神经网络和最近邻方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
9.00
自引率
0.00%
发文量
572
审稿时长
34 days
期刊介绍: The European Journal of Pharmacology publishes research papers covering all aspects of experimental pharmacology with focus on the mechanism of action of structurally identified compounds affecting biological systems. The scope includes: Behavioural pharmacology Neuropharmacology and analgesia Cardiovascular pharmacology Pulmonary, gastrointestinal and urogenital pharmacology Endocrine pharmacology Immunopharmacology and inflammation Molecular and cellular pharmacology Regenerative pharmacology Biologicals and biotherapeutics Translational pharmacology Nutriceutical pharmacology.
期刊最新文献
Genetic variations in GLP-1R: Impact on diabetes and obesity therapeutics Colchicine acutely reduces liver-secreted inflammatory and metabolic proteins in blood Integrative Mendelian randomization and experimental validation unveil novel druggable targets in primary biliary cholangitis 6-Shogaol ameliorates experimental colitis and colitis-associated colorectal cancer in mice through the Nrf2-Keap1 signaling pathway Cinnamaldehyde ameliorates diabetic kidney disease via anti-inflammatory effects: Bridging traditional use and molecular mechanisms
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1